{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:48:55Z","timestamp":1793065735532,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jval.2025.02.007","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T19:25:26Z","timestamp":1741116326000},"page":"1280-1287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["A Systematic Review and Meta-Analysis of Health-State Utility Values for Infectious Diseases With Pandemic Potential and Associated Vaccine Adverse Reactions"],"prefix":"10.1016","volume":"28","author":[{"given":"Taito","family":"Kitano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Salmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew Z.","family":"Dudley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian J.","family":"Saldanha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilly","family":"Engineer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jval.2025.02.007_bib1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S2215-0366(21)00025-0","article-title":"COVID-19 mental health impact and responses in low-income and middle-income countries: reimagining global mental health","volume":"8","author":"Kola","year":"2021","journal-title":"Lancet Psychiatry"},{"issue":"10334","key":"10.1016\/j.jval.2025.02.007_bib2","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(21)02796-3","article-title":"Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21","volume":"399","year":"2022","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jval.2025.02.007_bib3","doi-asserted-by":"crossref","first-page":"e759","DOI":"10.1016\/S2214-109X(21)00079-6","article-title":"Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis","volume":"9","author":"Chmielewska","year":"2021","journal-title":"Lancet Glob Health"},{"issue":"10344","key":"10.1016\/j.jval.2025.02.007_bib4","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1016\/S0140-6736(22)00008-3","article-title":"Quantifying the effects of the COVID-19 pandemic on gender equality on health, social, and economic indicators: a comprehensive review of data from March, 2020, to September, 2021","volume":"399","author":"Flor","year":"2022","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.jval.2025.02.007_bib5","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1473-3099(22)00320-6","article-title":"Global impact of the first year of COVID-19 vaccination: a mathematical modelling study","volume":"22","author":"Watson","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.jval.2025.02.007_bib6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1163\/15718093-BJA10042","article-title":"Pigs don\u2019t fly and you cannot expect absolutely safe COVID-19 vaccines (but you should expect a fair compensation)","volume":"28","author":"Raposo","year":"2021","journal-title":"Eur J Health Law"},{"issue":"1","key":"10.1016\/j.jval.2025.02.007_bib8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1478-7547-1-8","article-title":"Generalized cost-effectiveness analysis for national-level priority-setting in the health sector","volume":"1","author":"Hutubessy","year":"2003","journal-title":"Cost Eff Resour Alloc"},{"issue":"1","key":"10.1016\/j.jval.2025.02.007_bib9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1478-7954-10-21","article-title":"Systematic review of general burden of disease studies using disability-adjusted life years","volume":"10","author":"Polinder","year":"2012","journal-title":"Popul Health Metr"},{"key":"10.1016\/j.jval.2025.02.007_bib10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1146\/annurev.publhealth.23.100901.140513","article-title":"HALYS and QALYS and DALYS, Oh My: similarities and differences in summary measures of population Health","volume":"23","author":"Gold","year":"2002","journal-title":"Annu Rev Public Health"},{"issue":"4","key":"10.1016\/j.jval.2025.02.007_bib11","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/hex.13254","article-title":"Patient-reported outcome measures (PROMs): a review of generic and condition-specific measures and a discussion of trends and issues","volume":"24","author":"Churruca","year":"2021","journal-title":"Health Expect"},{"key":"10.1016\/j.jval.2025.02.007_bib12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12963-016-0091-3","article-title":"Summarizing health-related quality of life (HRQOL): development and testing of a one-factor model","volume":"14","author":"Yin","year":"2016","journal-title":"Popul Health Metr"},{"issue":"4","key":"10.1016\/j.jval.2025.02.007_bib13","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1586\/14737167.2013.818816","article-title":"Using health-related quality of life and quality-adjusted life expectancy for effective public health surveillance and prevention","volume":"13","author":"Brown","year":"2013","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"10","key":"10.1016\/j.jval.2025.02.007_bib14","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1007\/s11136-019-02214-9","article-title":"A systematic review of quality of life research in medicine and health sciences","volume":"28","author":"Haraldstad","year":"2019","journal-title":"Qual Life Res"},{"issue":"9","key":"10.1016\/j.jval.2025.02.007_bib15","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1631\/jzus.2005.B0936","article-title":"A systematic review: how to choose appropriate health-related quality of life (HRQOL) measures in routine general practice?","volume":"6","author":"Chen","year":"2005","journal-title":"J Zhejiang Univ Sci B"},{"key":"10.1016\/j.jval.2025.02.007_bib16","series-title":"Measuring and Valuing Health Benefits for Economic Evaluation","author":"Brazier","year":"2016"},{"issue":"1","key":"10.1016\/j.jval.2025.02.007_bib17","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1080\/13696998.2023.2195753","article-title":"A systematic review of SF-6D health state valuation studies","volume":"26","author":"Wang","year":"2023","journal-title":"J Med Econ"},{"issue":"12","key":"10.1016\/j.jval.2025.02.007_bib18","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/lary.21847","article-title":"Health state utility values in patients undergoing endoscopic sinus surgery","volume":"121","author":"Soler","year":"2011","journal-title":"Laryngoscope"},{"issue":"2","key":"10.1016\/j.jval.2025.02.007_bib19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1586\/14737167.2.2.99","article-title":"Health utility estimation","volume":"2","author":"Torrance","year":"2002","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"8","key":"10.1016\/j.jval.2025.02.007_bib20","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1007\/s11136-015-0926-6","article-title":"Why do multi-attribute utility instruments produce different utilities: the relative importance of the descriptive systems, scale and \u2018micro-utility\u2019 effects","volume":"24","author":"Richardson","year":"2015","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.jval.2025.02.007_bib21","doi-asserted-by":"crossref","first-page":"e962","DOI":"10.1093\/cid\/ciac151","volume":"75","author":"Sandmann","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.jval.2025.02.007_bib22","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s11136-020-02724-x","article-title":"Quality of life under the COVID-19 quarantine","volume":"30","author":"Ferreira","year":"2021","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jval.2025.02.007_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.991572","article-title":"Health-related quality of life in persons post-COVID-19 infection in comparison to normative controls and chronic pain patients","volume":"10","author":"Moens","year":"2022","journal-title":"Front Public Health"},{"issue":"1","key":"10.1016\/j.jval.2025.02.007_bib24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12955-019-1081-5","article-title":"Quality of life and utility decrement associated with Clostridium difficile infection in a French hospital setting","volume":"17","author":"Barbut","year":"2019","journal-title":"Health Qual Life Outcomes"},{"issue":"5","key":"10.1016\/j.jval.2025.02.007_bib25","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1016\/S1473-3099(20)30130-4","article-title":"The state of vaccine safety science: systematic reviews of the evidence","volume":"20","author":"Dudley","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"32","key":"10.1016\/j.jval.2025.02.007_bib27","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.15585\/mmwr.mm7032e4","article-title":"Use of COVID-19 vaccines after reports of adverse events among adult recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 vaccines (Pfizer-BioNTech and moderna): update from the Advisory Committee on Immunization Practices\u2014United States, July 2021","volume":"70","author":"Rosenblum","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.jval.2025.02.007_bib30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/vaccines9020111","article-title":"Inclusion of safety-related issues in economic evaluations for seasonal influenza vaccines: a systematic review","volume":"9","author":"Fens","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"10.1016\/j.jval.2025.02.007_bib32","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/irv.12510","article-title":"WHO guide on the economic evaluation of influenza vaccination","volume":"12","author":"Newall","year":"2018","journal-title":"Influ Other Respir Viruses"},{"key":"10.1016\/j.jval.2025.02.007_bib33","series-title":"National Institute for Health and Care Excellence, eds. National Institute for Health and Care Excellence (NICE): NICE Decision Support Unit Technical Support Documents","first-page":"16","article-title":"Technical Support Document 9: The Identification, Review and Synthesis of Health State Utility Values From the Literature","author":"Papaioannou","year":"2010"},{"issue":"3","key":"10.1016\/j.jval.2025.02.007_bib34","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jval.2019.01.004","article-title":"Identification Review Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report","volume":"22","author":"Brazier","year":"2019","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2025.02.007_bib35","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jval.2025.02.007_bib43","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jmv.27309","article-title":"Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)-a systematic review and meta-analysis","volume":"94","author":"Malik","year":"2022","journal-title":"J Med Virol"},{"issue":"10","key":"10.1016\/j.jval.2025.02.007_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0259164","article-title":"Impact of Covid-19 on health-related quality of life of patients: a structured review","volume":"16","author":"Poudel","year":"2021","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.jval.2025.02.007_bib45","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s40273-015-0310-y","article-title":"Is meta-analysis for utility values appropriate given the potential impact different elicitation methods have on values?","volume":"33","author":"Peasgood","year":"2015","journal-title":"Pharmacoeconomics"},{"issue":"9","key":"10.1016\/j.jval.2025.02.007_bib46","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s40273-018-0670-1","article-title":"A practical guide to conducting a systematic review and meta-analysis of health state utility values","volume":"36","author":"Petrou","year":"2018","journal-title":"Pharmacoeconomics"},{"issue":"11","key":"10.1016\/j.jval.2025.02.007_bib47","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jclinepi.2010.08.010","article-title":"Conducting quantitative synthesis when comparing medical interventions: AHRQ and the Effective Health Care Program","volume":"64","author":"Fu","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"10.1016\/j.jval.2025.02.007_bib48","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1398-9995.2009.01973.x","article-title":"Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions","volume":"64","author":"Brozek","year":"2009","journal-title":"Allergy"},{"issue":"7","key":"10.1016\/j.jval.2025.02.007_bib49","doi-asserted-by":"crossref","first-page":"A419","DOI":"10.1016\/j.jval.2016.09.419","article-title":"A systematic review of utilitiy weights for influenza and influenza-like illness","volume":"19","author":"Damm","year":"2016","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2025.02.007_bib50","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s44202-024-00204-8","article-title":"The impact of COVID-19 on health-related quality of life: a systematic review and evidence-based recommendations","volume":"4","author":"Xu","year":"2024","journal-title":"Discov Psychol"},{"issue":"1","key":"10.1016\/j.jval.2025.02.007_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/epirev\/mxae007","article-title":"Age- and sex-stratified risks of myocarditis and pericarditis attributable to COVID-19 vaccination: a systematic review and meta-analysis","volume":"47","author":"Kitano","year":"2025","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.jval.2025.02.007_bib52","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.smrv.2017.06.006","article-title":"Incidence of narcolepsy after H1N1 influenza and vaccinations: systematic review and meta-analysis","volume":"38","author":"Sarkanen","year":"2018","journal-title":"Sleep Med Rev"},{"issue":"12","key":"10.1016\/j.jval.2025.02.007_bib54","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/hec.1297","article-title":"Working Group on the Use of Evidence in Economic Decision Models. Use of evidence in economic decision models: practical issues and methodological challenges","volume":"16","author":"Cooper","year":"2007","journal-title":"Health Econ"},{"issue":"3","key":"10.1016\/j.jval.2025.02.007_bib55","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1017\/S0266462305050403","article-title":"Populating decision-analytic models: the feasibility and efficiency of database searching for individual parameters","volume":"21","author":"Golder","year":"2005","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.jval.2025.02.007_bib56","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijid.2020.08.021","article-title":"Lassa fever induced hearing loss: the neglected disability of hemorrhagic fever","volume":"100","author":"Ficenec","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jval.2025.02.007_bib57","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.tmaid.2017.05.001","article-title":"Neuropsychological long-term sequelae of Ebola virus disease survivors - a systematic review","volume":"18","author":"L\u00f6tsch","year":"2017","journal-title":"Travel Med Infect Dis"},{"issue":"7","key":"10.1016\/j.jval.2025.02.007_bib58","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/cid\/ciz1062","article-title":"Long-term complications of Ebola virus disease: prevalence and predictors of major symptoms and the role of inflammation","volume":"71","author":"Tozay","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.jval.2025.02.007_bib59","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/cid\/ciw158","article-title":"Ebola virus disease complications as experienced by survivors in Sierra Leone","volume":"62","author":"Tiffany","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.jval.2025.02.007_bib60","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1093\/cid\/ciab168","article-title":"Understanding long-term evolution and predictors of sequelae of Ebola virus disease survivors in guinea: a 48-month prospective, longitudinal cohort study (PostEboGui)","volume":"73","author":"Diallo","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.jval.2025.02.007_bib61","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024393","article-title":"Comparison of multisystem inflammatory syndrome in children-related myocarditis, classic viral myocarditis, and COVID-19 vaccine-related myocarditis in children","volume":"11","author":"Patel","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jval.2025.02.007_bib62","article-title":"Guillain-Barre syndrome following COVID-19 vaccines: a review of literature","volume":"14","author":"Yu","year":"2023","journal-title":"Front Immunol"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301525000853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301525000853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T03:17:24Z","timestamp":1785554244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301525000853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1098301525000853"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2025.02.007","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Systematic Review and Meta-Analysis of Health-State Utility Values for Infectious Diseases With Pandemic Potential and Associated Vaccine Adverse Reactions","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2025.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}